Codes / ICD10CM / H02.881

H02.881 Meibomian gland dysfunction right upper eyelid

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Meibomian Gland Dysfunction Right Upper Eyelid

Summary

Meibomian gland dysfunction (MGD) is a condition affecting the meibomian glands in the eyelids, which produce the oily layer of the tear film. When this dysfunction occurs in the right upper eyelid, it can lead to dry, irritated eyes due to inadequate lubrication of the ocular surface.

Causes

MGD is primarily caused by blockages or structural changes in the meibomian glands. These changes may result from aging, hormonal imbalances, chronic inflammation, or underlying skin conditions like rosacea. Abnormal secretion or thickening of glandular secretions can also contribute to the condition.

Risk Factors

  • Aging, as gland function tends to decline with time.
  • Hormonal fluctuations, particularly in post-menopausal individuals.
  • History of inflammatory skin conditions, such as rosacea or seborrheic dermatitis.
  • Use of contact lenses or certain medications that affect tear production.
  • Prolonged screen time, which reduces blink rate and may exacerbate symptoms.

Symptoms

  • Dryness, irritation, or a gritty sensation in the eyes.
  • Blurred vision or sensitivity to light.
  • Redness, swelling, or inflammation of the eyelids.
  • Excessive tearing or crusting along the eyelid margins.
  • Discomfort or burning sensation, especially upon waking.

Diagnosis

Diagnosis is typically based on a comprehensive eye examination, including slit-lamp evaluation and assessment of meibomian gland function. The clinician may manually express the glands to check for blockages or abnormal secretions. Additional tests, such as tear break-up time or meibography, may be used to confirm the diagnosis.

Treatment Options

  • Warm compresses to help unblock gland ducts.
  • Lid massages and cleaning to maintain eyelid hygiene.
  • Artificial tears or lubricating eye drops to alleviate dryness.
  • Omega-3 supplements to improve gland function (if recommended by a provider).
  • Prescription medications, such as anti-inflammatory drops or antibiotics, for severe cases.

Prognosis and Follow-Up

With proper management, symptoms often improve, but MGD is typically chronic and may require ongoing treatment. Regular follow-up with an eye care provider is recommended to monitor gland function and adjust treatment as needed.

Complications

Untreated MGD can lead to chronic dry eye, corneal irritation, or increased risk of eye infections. Severe cases may result in vision changes or discomfort that impacts daily activities.

Lifestyle & Prevention

  • Practice good eyelid hygiene, including gentle cleaning with a warm washcloth.
  • Avoid rubbing the eyes, which can worsen irritation.
  • Use a humidifier to reduce dryness in indoor environments.
  • Take regular breaks from screen time to promote blinking.
  • Wear sunglasses outdoors to protect the eyes from wind and debris.

When to Seek Professional Help

Seek care if symptoms persist despite home care, worsen over time, or are accompanied by vision changes, severe pain, or signs of infection (e.g., pus, increased redness).

Tips for Medical Coders

Document the specific eyelid (right upper) and laterality (right) to support accurate coding. Include clinical details such as gland expression findings, associated symptoms, or treatment responses to clarify the diagnosis. Ensure documentation aligns with the specificity of H02.881 for precise coding.

Book a walkthrough

H02.881 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.